Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

24.02
+0.34001.44%
Post-market: 24.310.2860+1.19%16:10 EDT
Volume:1K
Turnover:26.00K
Market Cap:4.80M
PE:- -
High:24.02
Open:23.78
Low:23.78
Close:23.68
52wk High:24.29
52wk Low:15.67
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.71
T/O Rate:0.54%
Dividend:0.77
Dividend Rate:3.21%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna (MRNA) Receives a Hold from Bernstein

TIPRANKS
·
Sep 25

INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours

Benzinga Earnings
·
Sep 25

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Dow Jones
·
Sep 25

Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know

TradingKey
·
Sep 25

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 25

Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis

TradingKey
·
Sep 24

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

TradingKey
·
Sep 24

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Reuters
·
Sep 24

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
Sep 24

Leerink Sees Life-Science Tools Benefiting from Anthropic's Push into Biology

Reuters
·
Sep 24

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24

Insmed resumed with a Buy at Goldman Sachs

TIPRANKS
·
Sep 24

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 24

Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 24

Editas slips amid pressure on gene-editing sector after Anthropic update

TIPRANKS
·
Sep 24

Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker is Going Next

Dow Jones
·
Sep 24

Moderna rises 4.6%

TIPRANKS
·
Sep 23

Early notable gainers among liquid option names on September 23rd

TIPRANKS
·
Sep 23